Interstitial lung disease (ILD) is a collection of chronic diseases affecting the lungs, some of which have a similar life expectancy to heart failure and lung cancer. NICE guidelines have made recommendations for treatment of usual interstitial pneumonia (UIP) with Perfenidone. They have also recommended strict criteria for assessment and prescription.
The Imaging Clinical Network will include all radiology departments within the region to standardise and design a protocol for CT reporting for UIP. The network will then monitor against this to formulate a standard referral criteria for Perfenidone treatment. The key objective is to measure scans reported using the standardised template, reduce variation in patients referred to regional ILD centres and enable second opinions in ILD.
The network has initially identified ILD reporters in the network and a proforma has been created. It is being trialled at Oxford University Hospitals NHS Foundation Trust before being rolled out across the Oxford AHSN region.